IN8BIO, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
IN8BIO, INC. (INAB) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.33 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- IN8BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 2.33M shares, a 13.69% increase year-over-year.
- IN8BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.80M shares, a 20.54% decline year-over-year.
- IN8BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 1.94M shares, a 77.00% increase year-over-year.
- IN8BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 2.05M shares, a 91.19% increase year-over-year.
- IN8BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.00M shares, a 49.50% increase from fiscal 2024.
- IN8BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.34M shares, a 87.45% decline from fiscal 2023.
- IN8BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 10.68M shares, a 233.83% increase from fiscal 2022.
- IN8BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 3.20M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.33M shares 10-Q · filed 2026-08-06 | 2.07M shares 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | 1.80M shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 2.00M shares 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | 1.94M shares 10-Q · filed 2025-11-06 | 2.09M shares 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | 2.05M shares 10-Q · filed 2026-08-06 | 2.16M shares 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | 2.27M shares 10-Q · filed 2026-05-07 | 68.03M shares 10-Q · filed 2025-05-07 | ||||||
| 2024-12-31 | 1.34M shares 10-K · filed 2026-03-12 | 40.21M shares 10-K · filed 2025-03-13 | ||||||
| 2024-09-30 | 1.10M shares 10-Q · filed 2025-11-06 | 32.86M shares 10-Q · filed 2024-11-12 | 1.07M shares 10-Q · filed 2025-11-06 | 32.15M shares 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | 1.07M shares 10-Q · filed 2025-08-07 | 32.22M shares 10-Q · filed 2024-08-08 | 1.06M shares 10-Q · filed 2025-08-07 | 31.79M shares 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | 31.36M shares 10-Q · filed 2025-05-07 | 31.93M shares 10-Q · filed 2024-05-09 | ||||||
| 2023-12-31 | 10.68M shares 10-K · filed 2025-03-13 | |||||||
| 2023-09-30 | 6.75M shares 10-Q · filed 2024-11-12 | 5.35M shares 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | 5.41M shares 10-Q · filed 2024-08-08 | 4.64M shares 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | 3.87M shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 3.20M shares 10-K · filed 2024-03-14 | |||||||
| 2021-06-30 | 9.99M shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |